1 results match your criteria: "Oncology Department of Hospital Nostra Senyora de Meritxell[Affiliation]"
Seroprevalence study prior and post vaccination in cancer patients in principality of Andorra (COVONCO study).
J Cancer Res Clin Oncol
July 2023
Oncology Department of Hospital Nostra Senyora de Meritxell, SAAS, Escaldes-Engordany, Andorra.
Article Synopsis
- The study investigates COVID-19 serologic responses in cancer patients in Andorra, noting that their responses may be lower compared to the general population and can depend on tumor type and cancer treatments.
- A total of 373 oncologic patients were analyzed, revealing an increase in seroprevalence from 13% to 19%, with notably lower rates in those with hematologic malignancies and those on biological therapies.
- Women and tumor-free patients exhibited higher seroprevalence, with vaccination showing varying effectiveness: those vaccinated with ChAdOx1-S had a higher seroprevalence than those vaccinated with BNT162b2.